Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 393

1.

KSP siRNA/paclitaxel-loaded PEGylated cationic liposomes for overcoming resistance to KSP inhibitors: Synergistic antitumor effects in drug-resistant ovarian cancer.

Lee J, Cho YJ, Lee JW, Ahn HJ.

J Control Release. 2020 Feb 5. pii: S0168-3659(20)30090-0. doi: 10.1016/j.jconrel.2020.02.013. [Epub ahead of print]

PMID:
32035195
2.

Arrangement optimization of water-driven triboelectric nanogenerators considering capillary phenomenon between hydrophobic surfaces.

Park HR, Lee JW, Kim DS, Sim JY, Song I, Hwang W.

Sci Rep. 2020 Jan 24;10(1):1126. doi: 10.1038/s41598-020-57851-9.

3.

Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical Cancer.

Choi CH, Choi HJ, Lee JW, Kang ES, Cho D, Park BK, Kim YM, Kim DY, Seo H, Park M, Kim W, Choi KY, Oh T, Kang CY, Kim BG.

J Clin Med. 2020 Jan 5;9(1). pii: E147. doi: 10.3390/jcm9010147.

4.

Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study.

Park SJ, Kim J, Kim HS, Lee JW, Chang HK, Lee KH, Kim DY, Kim S, Chang SJ, Han SS, Park SY, Shim SH.

J Gynecol Oncol. 2019 Sep 10. doi: 10.3802/jgo.2020.31.e15. [Epub ahead of print]

5.

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer.

Jeong SY, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS, Lee YY.

J Ovarian Res. 2019 Dec 31;13(1):1. doi: 10.1186/s13048-019-0602-5.

6.

Cytoplasmic expression of EGFR shRNA using a modified T7 autogene-based hybrid mRNA/DNA system induces long-term EGFR silencing and prolongs antitumor effects.

Seraj S, Cho YJ, Lee JW, Ahn HJ.

Biochem Pharmacol. 2020 Jan;171:113735. doi: 10.1016/j.bcp.2019.113735. Epub 2019 Nov 29.

PMID:
31786264
7.

Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea.

Seo JH, Jeong SY, Kim MS, Kang JH, Paik ES, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH.

Obstet Gynecol Sci. 2019 Nov;62(6):411-419. doi: 10.5468/ogs.2019.62.6.411. Epub 2019 Oct 11.

8.

CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer.

Kim J, Cho YJ, Ryu JY, Hwang I, Han HD, Ahn HJ, Kim WY, Cho H, Chung JY, Hewitt SM, Kim JH, Kim BG, Bae DS, Choi CH, Lee JW.

Gynecol Oncol. 2020 Jan;156(1):211-221. doi: 10.1016/j.ygyno.2019.11.004. Epub 2019 Nov 24.

PMID:
31776040
9.

Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers.

Sa JK, Hwang JR, Cho YJ, Ryu JY, Choi JJ, Jeong SY, Kim J, Kim MS, Paik ES, Lee YY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee Y, Her NG, Shin YJ, Cho HJ, Kim JY, Seo YJ, Koo H, Oh JW, Lee T, Kim HS, Song SY, Bae JS, Park WY, Han HD, Ahn HJ, Sood AK, Rabadan R, Lee JK, Nam DH, Lee JW.

Genome Biol. 2019 Nov 26;20(1):253. doi: 10.1186/s13059-019-1848-3.

10.

Comparison between Laparoendoscopic Single-Site and Conventional Laparoscopic Surgery in Mature Cystic Teratoma of the Ovary.

Kim MS, Choi CH, Lee JW, Kim BG, Bae DS, Kim TJ.

Gynecol Minim Invasive Ther. 2019 Oct 24;8(4):155-159. doi: 10.4103/GMIT.GMIT_3_19. eCollection 2019 Oct-Dec.

11.

Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status.

Jeong SY, Park H, Kim MS, Kang JH, Paik ES, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH.

Cancer Res Treat. 2019 Oct 29. doi: 10.4143/crt.2019.328. [Epub ahead of print]

12.

Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer.

Lee YY, Cho YJ, Shin SW, Choi C, Ryu JY, Jeon HK, Choi JJ, Hwang JR, Choi CH, Kim TJ, Kim BG, Bae DS, Park W, Lee JW.

Sci Rep. 2019 Oct 28;9(1):15394. doi: 10.1038/s41598-019-51959-3.

13.

Clinical significance of lymph node size in locally advanced cervical cancer treated with concurrent chemoradiotherapy.

Oh J, Seol KH, Choi YS, Lee JW, Bae JY.

Yeungnam Univ J Med. 2019 May;36(2):115-123. doi: 10.12701/yujm.2019.00143. Epub 2019 Feb 21.

14.

The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02.

Lee JW, Oh D, Eom KY, Kim JH, Kim WC, Chung MJ, Lee JH.

Clin Exp Metastasis. 2020 Feb;37(1):125-131. doi: 10.1007/s10585-019-09992-z. Epub 2019 Sep 25.

PMID:
31555945
15.

Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.

Lee JW, Son MW, Chung IK, Cho YS, Lee MS, Lee SM.

Gastric Cancer. 2019 Sep 4. doi: 10.1007/s10120-019-01001-2. [Epub ahead of print]

PMID:
31485803
16.

Prognostic Significance of Abdominal-to-Gluteofemoral Adipose Tissue Distribution in Patients with Breast Cancer.

Lee JW, Kim SY, Lee HJ, Han SW, Lee JE, Lee SM.

J Clin Med. 2019 Sep 1;8(9). pii: E1358. doi: 10.3390/jcm8091358.

17.

Prognostic Significance of CT-Attenuation of Tumor-Adjacent Breast Adipose Tissue in Breast Cancer Patients with Surgical Resection.

Lee JW, Kim SY, Lee HJ, Han SW, Lee JE, Lee SM.

Cancers (Basel). 2019 Aug 8;11(8). pii: E1135. doi: 10.3390/cancers11081135.

18.

Effect of F-18 Fluorodeoxyglucose Uptake by Bone Marrow on the Prognosis of Head and Neck Squamous Cell Carcinoma.

Lee JW, Ban MJ, Park JH, Lee SM.

J Clin Med. 2019 Aug 4;8(8). pii: E1169. doi: 10.3390/jcm8081169.

19.

Hypofractionated radiotherapy for early glottic cancer: a retrospective interim analysis of a single institution.

Lee JW, Lee JE, Park J, Sohn JH, Ahn D.

Radiat Oncol J. 2019 Jun;37(2):82-90. doi: 10.3857/roj.2019.00143. Epub 2019 Jun 30.

20.

Supplemental Content

Loading ...
Support Center